vs

Side-by-side financial comparison of Core Laboratories Inc. (CLB) and Porch Group, Inc. (PRCH). Click either name above to swap in a different company.

Core Laboratories Inc. is the larger business by last-quarter revenue ($121.8M vs $121.1M, roughly 1.0× Porch Group, Inc.). Core Laboratories Inc. runs the higher net margin — 4.2% vs -3.9%, a 8.1% gap on every dollar of revenue. On growth, Porch Group, Inc. posted the faster year-over-year revenue change (100.0% vs -1.4%). Over the past eight quarters, Porch Group, Inc.'s revenue compounded faster (26.4% CAGR vs -3.4%).

Abbott Laboratories, commonly known as Abbott, is an American multinational medical devices and health care company with headquarters in Abbott Park, Illinois. The company produces pharmaceuticals for sale outside the United States, diagnostic products, nutritional products, and medical devices.

Porch is a website that tries to connect homeowners with local home improvement contractors. The site features advice articles, cost guide, and online booking for over 160 home projects.

CLB vs PRCH — Head-to-Head

Bigger by revenue
CLB
CLB
1.0× larger
CLB
$121.8M
$121.1M
PRCH
Growing faster (revenue YoY)
PRCH
PRCH
+101.4% gap
PRCH
100.0%
-1.4%
CLB
Higher net margin
CLB
CLB
8.1% more per $
CLB
4.2%
-3.9%
PRCH
Faster 2-yr revenue CAGR
PRCH
PRCH
Annualised
PRCH
26.4%
-3.4%
CLB

Income Statement — Q1 FY2026 vs Q1 FY2026

Metric
CLB
CLB
PRCH
PRCH
Revenue
$121.8M
$121.1M
Net Profit
$5.1M
$-4.7M
Gross Margin
52.7%
Operating Margin
1.5%
34.7%
Net Margin
4.2%
-3.9%
Revenue YoY
-1.4%
100.0%
Net Profit YoY
2.0%
EPS (diluted)
$0.11
$-0.04

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CLB
CLB
PRCH
PRCH
Q1 26
$121.8M
$121.1M
Q4 25
$138.3M
$112.3M
Q3 25
$134.5M
$115.1M
Q2 25
$130.2M
$107.0M
Q1 25
$123.6M
$84.5M
Q4 24
$129.2M
$75.3M
Q3 24
$134.4M
$77.7M
Q2 24
$130.6M
$75.9M
Net Profit
CLB
CLB
PRCH
PRCH
Q1 26
$5.1M
$-4.7M
Q4 25
$4.9M
$-3.5M
Q3 25
$14.2M
$-10.9M
Q2 25
$10.6M
$2.6M
Q1 25
$-154.0K
$8.4M
Q4 24
$7.4M
$30.5M
Q3 24
$11.7M
$14.4M
Q2 24
$9.0M
$-64.3M
Gross Margin
CLB
CLB
PRCH
PRCH
Q1 26
52.7%
Q4 25
20.8%
99.5%
Q3 25
22.0%
75.6%
Q2 25
20.3%
70.9%
Q1 25
19.5%
77.4%
Q4 24
17.8%
Q3 24
20.5%
79.4%
Q2 24
21.2%
22.1%
Operating Margin
CLB
CLB
PRCH
PRCH
Q1 26
1.5%
34.7%
Q4 25
11.5%
14.7%
Q3 25
15.6%
14.2%
Q2 25
11.7%
4.7%
Q1 25
3.6%
-1.5%
Q4 24
11.0%
33.3%
Q3 24
14.7%
-3.2%
Q2 24
12.3%
-69.2%
Net Margin
CLB
CLB
PRCH
PRCH
Q1 26
4.2%
-3.9%
Q4 25
3.6%
-3.1%
Q3 25
10.6%
-9.4%
Q2 25
8.2%
2.4%
Q1 25
-0.1%
9.9%
Q4 24
5.7%
40.5%
Q3 24
8.7%
18.5%
Q2 24
6.9%
-84.8%
EPS (diluted)
CLB
CLB
PRCH
PRCH
Q1 26
$0.11
$-0.04
Q4 25
$0.11
$0.00
Q3 25
$0.30
$-0.10
Q2 25
$0.22
$0.00
Q1 25
$0.00
$0.07
Q4 24
$0.15
$0.34
Q3 24
$0.25
$0.12
Q2 24
$0.19
$-0.65

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CLB
CLB
PRCH
PRCH
Cash + ST InvestmentsLiquidity on hand
$22.8M
$68.4M
Total DebtLower is stronger
$391.3M
Stockholders' EquityBook value
$275.1M
$26.3M
Total Assets
$587.7M
$806.6M
Debt / EquityLower = less leverage
14.87×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CLB
CLB
PRCH
PRCH
Q1 26
$22.8M
$68.4M
Q4 25
$22.7M
$57.3M
Q3 25
$25.6M
$85.0M
Q2 25
$31.2M
$79.8M
Q1 25
$22.1M
$70.4M
Q4 24
$19.2M
$191.7M
Q3 24
$21.5M
$238.6M
Q2 24
$17.7M
$308.4M
Total Debt
CLB
CLB
PRCH
PRCH
Q1 26
$391.3M
Q4 25
$110.3M
$392.8M
Q3 25
$114.1M
$387.1M
Q2 25
$124.6M
$394.1M
Q1 25
$124.4M
$409.2M
Q4 24
$126.1M
$403.9M
Q3 24
$139.9M
$399.0M
Q2 24
$147.6M
$436.8M
Stockholders' Equity
CLB
CLB
PRCH
PRCH
Q1 26
$275.1M
$26.3M
Q4 25
$266.0M
$-24.6M
Q3 25
$271.3M
$-27.9M
Q2 25
$261.3M
$-29.3M
Q1 25
$253.4M
$-52.4M
Q4 24
$246.6M
$-43.2M
Q3 24
$250.7M
$-77.0M
Q2 24
$240.3M
$-101.9M
Total Assets
CLB
CLB
PRCH
PRCH
Q1 26
$587.7M
$806.6M
Q4 25
$584.0M
$797.4M
Q3 25
$591.4M
$787.7M
Q2 25
$602.1M
$770.7M
Q1 25
$591.5M
$802.3M
Q4 24
$585.1M
$814.0M
Q3 24
$600.5M
$867.3M
Q2 24
$597.8M
$876.1M
Debt / Equity
CLB
CLB
PRCH
PRCH
Q1 26
14.87×
Q4 25
0.41×
Q3 25
0.42×
Q2 25
0.48×
Q1 25
0.49×
Q4 24
0.51×
Q3 24
0.56×
Q2 24
0.61×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CLB
CLB
PRCH
PRCH
Operating Cash FlowLast quarter
$4.0M
Free Cash FlowOCF − Capex
$517.0K
FCF MarginFCF / Revenue
0.4%
Capex IntensityCapex / Revenue
Cash ConversionOCF / Net Profit
0.77×
TTM Free Cash FlowTrailing 4 quarters
$22.5M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CLB
CLB
PRCH
PRCH
Q1 26
$4.0M
Q4 25
$7.9M
$1.2M
Q3 25
$8.5M
$40.8M
Q2 25
$13.9M
$35.6M
Q1 25
$6.7M
$-11.2M
Q4 24
$20.6M
$-26.6M
Q3 24
$13.1M
$12.4M
Q2 24
$17.1M
$-26.0M
Free Cash Flow
CLB
CLB
PRCH
PRCH
Q1 26
$517.0K
Q4 25
$5.0M
$1.1M
Q3 25
$6.5M
$40.7M
Q2 25
$10.4M
$35.4M
Q1 25
$3.9M
$-11.2M
Q4 24
$17.4M
$-26.8M
Q3 24
$10.4M
$12.2M
Q2 24
$14.3M
$-26.0M
FCF Margin
CLB
CLB
PRCH
PRCH
Q1 26
0.4%
Q4 25
3.6%
1.0%
Q3 25
4.8%
35.4%
Q2 25
8.0%
33.0%
Q1 25
3.1%
-13.3%
Q4 24
13.4%
-35.6%
Q3 24
7.7%
15.7%
Q2 24
10.9%
-34.3%
Capex Intensity
CLB
CLB
PRCH
PRCH
Q1 26
Q4 25
2.1%
0.1%
Q3 25
1.5%
0.1%
Q2 25
2.7%
0.2%
Q1 25
2.3%
0.1%
Q4 24
2.5%
0.3%
Q3 24
2.0%
0.3%
Q2 24
2.2%
0.1%
Cash Conversion
CLB
CLB
PRCH
PRCH
Q1 26
0.77×
Q4 25
1.61×
Q3 25
0.60×
Q2 25
1.31×
13.79×
Q1 25
-1.33×
Q4 24
2.78×
-0.87×
Q3 24
1.12×
0.86×
Q2 24
1.90×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons